218 related articles for article (PubMed ID: 35790245)
1. The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.
Shen Y; Eades W; Liu W; Yan B
Drug Metab Dispos; 2022 Sep; 50(9):1151-1160. PubMed ID: 35790245
[TBL] [Abstract][Full Text] [Related]
2. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
[TBL] [Abstract][Full Text] [Related]
3. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
[TBL] [Abstract][Full Text] [Related]
4. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
[TBL] [Abstract][Full Text] [Related]
5. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
[TBL] [Abstract][Full Text] [Related]
7. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
[TBL] [Abstract][Full Text] [Related]
8. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity Drug.
Hirosawa K; Fukami T; Nakano M; Nakajima M
Drug Metab Dispos; 2023 Aug; 51(8):1016-1023. PubMed ID: 37137721
[TBL] [Abstract][Full Text] [Related]
10. Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC.
Honda S; Fukami T; Tsujiguchi T; Zhang Y; Nakano M; Nakajima M
Eur J Pharm Sci; 2021 Jun; 161():105807. PubMed ID: 33722734
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the inhibition of human carboxylesterases (CESs) by the active ingredients from
Fu Q; Yang K; Hu RX; Du Z; Hu CM; Zhang X
Xenobiotica; 2019 Nov; 49(11):1260-1268. PubMed ID: 30486721
[TBL] [Abstract][Full Text] [Related]
12. Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans.
Honda S; Fukami T; Hirosawa K; Tsujiguchi T; Zhang Y; Nakano M; Uehara S; Uno Y; Yamazaki H; Nakajima M
Drug Metab Dispos; 2021 Sep; 49(9):718-728. PubMed ID: 34135089
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.
Sanghani SP; Quinney SK; Fredenburg TB; Davis WI; Murry DJ; Bosron WF
Drug Metab Dispos; 2004 May; 32(5):505-11. PubMed ID: 15100172
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.
Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
[TBL] [Abstract][Full Text] [Related]
15. The Crystal Structure of Mouse Ces2c, a Potential Ortholog of Human CES2, Shows Structural Similarities in Substrate Regulation and Product Release to Human CES1.
Eisner H; Riegler-Berket L; Gamez CFR; Sagmeister T; Chalhoub G; Darnhofer B; Jazleena PJ; Birner-Gruenberger R; Pavkov-Keller T; Haemmerle G; Schoiswohl G; Oberer M
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361897
[TBL] [Abstract][Full Text] [Related]
16. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review.
Liu Y; Li J; Zhu HJ
Expert Opin Drug Metab Toxicol; 2024 May; 20(5):377-397. PubMed ID: 38706437
[TBL] [Abstract][Full Text] [Related]
17. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
Laizure SC; Parker RB; Herring VL; Hu ZY
Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
[TBL] [Abstract][Full Text] [Related]
18. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
[TBL] [Abstract][Full Text] [Related]
19. Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir.
Jemth AS; Scaletti ER; Homan E; Stenmark P; Helleday T; Michel M
J Biol Chem; 2022 Aug; 298(8):102169. PubMed ID: 35732208
[TBL] [Abstract][Full Text] [Related]
20. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Merali Z; Ross S; Paré G
Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
